SERUM PROTEOMIC PROFILING CAN DISCRIMINATE PROSTATE CANCER FROM BENIGN PROSTATES IN MEN WITH TOTAL PROSTATE SPECIFIC ANTIGEN LEVELS BETWEEN 2.5 AND 15.0 NG/ML-Reference-Cited by-同舟云学术

SERUM PROTEOMIC PROFILING CAN DISCRIMINATE PROSTATE CANCER FROM BENIGN PROSTATES IN MEN WITH TOTAL PROSTATE SPECIFIC ANTIGEN LEVELS BETWEEN 2.5 AND 15.0 NG/ML

Published:2004-10 Issue:4 Part 1 Volume:172 Page:1302-1305
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

ORNSTEIN DAVID K.¹,RAYFORD WALTER¹,FUSARO VINCENT A.¹,CONRADS THOMAS P.¹,ROSS SALLY J.¹,HITT BEN A.¹,WIGGINS WESLEY W.¹,VEENSTRA TIMOTHY D.¹,LIOTTA LANCE A.¹,PETRICOIN EMANUEL F.¹

Affiliation:

1. From the Lineberger Comprehensive Cancer Center, University of North Carolina (DKO), Chapel Hill, North Carolina, Department of Urology, Louisiana State University (WR), New Orleans, Louisiana, and Clinical Proteomics Program, Food and Drug Administration/National Institutes of Health (VAF, TPC, SJR, TDV, LAL, EFP) and Correlogic Systems (BAH, WWW), Bethesda, Maryland

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Cancer Surveillance Series: Interpreting Trends in Prostate Cancer Part I: Evidence of the Effects of Screening in Recent Prostate Cancer Incidence, Mortality, and Survival Rates

2. Prostate-specific antigen

3. Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease

4. COMPLEXED PROSTATE SPECIFIC ANTIGEN PROVIDES SIGNIFICANT ENHANCEMENT OF SPECIFICITY COMPARED WITH TOTAL PROSTATE SPECIFIC ANTIGEN FOR DETECTING PROSTATE CANCER

5. Proteomic applications for the early detection of cancer

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Artificial Intelligence the Key to Revolutionizing Benign Prostatic Hyperplasia Diagnosis and Management?;Archivos Españoles de Urología;2023

2. A Combined Near-Infrared and Mid-Infrared Spectroscopic Approach for the Detection and Quantification of Glycine in Human Serum;Sensors;2022-06-15

3. The Predictive Role of Prostate-Specific Antigen Changes Following Transurethral Resection of the Prostate for Patients with Localized Prostate Cancer;Cancers;2020-12-29

4. Origins, Technological Development, and Applications of Peptidomics;Methods in Molecular Biology;2018

5. Screening and Identification of Molecular Marker for Metastatic Liver Cancer;Multidisciplinary Management of Liver Metastases in Colorectal Cancer;2016-12-15